Research Information System
Kafkas J Med Sci, vol.5, no.3, pp.109-119, 2015 (Peer-Reviewed Journal)
Endometriosisis a very common gynecological condition causing
infertility and pelvic pain affecting 6%–10% of women at their reproductive ages. The prevalence is 20%–50% and 20%–70% in
infertile women and women with chronic pelvic pain, respectively.
The treatment of endometriosisis is always challenging for healthcare professionals and there is no curative treatment option for
endometriosis.
The treatment options for endometriosis can be classifi ed as medical, surgical or combinations of the two approaches. Different
medical agents exist for treatment of endometriosis. The most
commonly used of these medical agents are non-steroidal antiinfl ammatory drugs, analgesics, gestagens or their derivatives,
combined oral contraceptive pills, and more recently the levonorgestrel intrauterine system. Although there are numerous treatment
options, available pharmacological treatment options in endometriosis are not fully satisfactory. Numerous new medical treatment agents are currently being tested in clinical trials in different
phases. The purpose of the present review is to discuss the new
medical treatment modalities in endometriosis.
Key words: endometriosis; medical treatment; pelvic pai